Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry

被引：39

作者：

Corbett, DF

Heightman, TD

Moss, SF

Bromidge, SM

Coggon, SA

Longley, MJ

Roa, AM

Williams, JA

Thomas, DR

机构：

[1] GlaxoSmithKline Inc, Discovery Res, High Throughput Chem, Harlow CM19 5AW, Essex, England

[2] GlaxoSmithKline Inc, Neurol & GI Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England

[3] GlaxoSmithKline Inc, Psychiat Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England

[4] Glaxo SmithKline Pharmaceut, Screening Sci Dept, Ctr Invest Basica, Madrid 28760, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 18期

关键词：

5-ht(5A) receptor; 5-ht(5A) antagonist; high-throughput chemistry; solid-phase synthesis;

D O I：

10.1016/j.bmcl.2005.06.024

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

High-throughput screening of an array of biphenylmethylamines synthesised by high-throughput solid-phase chemistry resulted in the identification of compounds with high-affinity for the 5-ht(5A) receptor. The structure-activity relationship within this series and further array synthesis led to the identification of the biphenylmethylamine derivative 11, a potent and selective 5-ht(5A) receptor antagonist. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：4014 / 4018

页数：5

共 50 条

[41] Serotonin receptor 5-HT5A in rat hippocampus decrease by leptin treatment
Garcia-Alcocer, Guadalupe
Rodriguez, Angelina
Moreno-Layseca, Paulina
Berumen, Laura C.
Escobar, Jesica
Miledi, Ricardo
NEUROSCIENCE LETTERS, 2010, 486 (03) : 171 - 173
[42] Preclinical Characterization and Functional Mechanism of ASP5736, a Selective Serotonin 5-HT5A Receptor Antagonist with Potential Utility for the Treatment of Schizophrenia and Affective Disorders
Yamazaki, Mayako
Yarimizu, Junko
Harada, Katsuya
Yamamoto, Noriyuki
Okabe, Mayuko
Ni, Keni Ni
Marcus, Monica
Svensson, Torgny
Matsumoto, Mitsuyuki
NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S595 - S596
[43] Functional role of serotonin 5-HT5A receptors in cognition: Mechanism of action study with a selective antagonist ASP5736
Yamamoto, N.
Yarimizu, J.
Yamazaki, M.
Harada, K.
Okabe, M.
Ni, K.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 63 - 63
[44] Localization of 5-ht5A receptor-like immunoreactivity in the rat brain
Oliver, KR
Kinsey, AM
Wainwright, A
Sirinathsinghji, DJS
BRAIN RESEARCH, 2000, 867 (1-2) : 131 - 142
[45] The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo
Beattie, DT
Smith, JAM
Marquess, D
Vickery, RG
Armstrong, SR
Pulido-Rios, T
McCullough, JL
Sandlund, C
Richardson, C
Mai, N
Humphrey, PPA
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 549 - 560
[46] ANTITHROMBOTIC ACTIVITY OF SR46349, A NOVEL, POTENT AND SELECTIVE 5-HT2 RECEPTOR ANTAGONIST
HERBERT, JM
BERNAT, A
BARTHELEMY, G
DOL, F
RINALDI, M
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (03) : 262 - 267
[47] Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands:: Optimising brain penetration
Peters, Jens-Uwe
Luebbers, Thomas
Alanine, Alexander
Kolczewski, Sabine
Blasco, Francesca
Steward, Lucinda
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 262 - 266
[48] RS-39604 - A POTENT, SELECTIVE AND ORALLY-ACTIVE 5-HT4 RECEPTOR ANTAGONIST
HEGDE, SS
BONHAUS, DW
JOHNSON, LG
LEUNG, E
CLARK, RD
EGLEN, RM
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) : 1087 - 1095
[49] Characterization of SB-271046:: A potent, selective and orally active 5-HT6 receptor antagonist
Routledge, C
Bromidge, SM
Moss, SF
Price, GW
Hirst, W
Newman, H
Riley, G
Gager, T
Stean, T
Upton, N
Clarke, SE
Brown, AM
Middlemiss, DN
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (07) : 1606 - 1612
[50] SB 207266: The first potent and selective 5-HT4 receptor antagonist amide with oral activity
Wardle, KA
Bingham, S
Ellis, ES
Gaster, LM
Rushant, B
Smith, MI
Brown, AM
Young, TJ
Sanger, GJ
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P126 - P126

← 1 2 3 4 5 →